USE OF EXTRAORAL PHOTOBIOMODULATION IN THE MANAGEMENT OF ORAL MUCOSITIS: SYSTEMATIC LITERATURE REVIEW

Taliane Lomba Dias Julião; Esther de Santana Brito; Julianna de Freitas Ferreira; Luiz Alexandre da Luz de Almeida; Júlia dos Santos Vianna Néri; Daniel Adrian Daniel Adrian Silva Souza; Juliana Borges de Lima Dantas

doi:10.5327/2525-5711.447

Autores

Taliane Lomba Dias Julião Graduated in Dentistry of the Adventist College of Bahia. Highway BR 101, Km 197, Cachoeira, Bahia, Brazil. https://orcid.org/0009-0007-4471-2965
Esther de Santana Brito Graduated in Dentistry of the Adventist College of Bahia. Highway BR 101, Km 197, Cachoeira, Bahia, Brazil. https://orcid.org/0009-0000-0598-9389
Julianna de Freitas Ferreira Dentistry student of the Adventist College of Bahia. Highway BR 101, Km 197, Cachoeira, Bahia, Brazil. https://orcid.org/0009-0008-6485-6701
Luiz Alexandre da Luz de Almeida Graduated in Dentistry of the Adventist College of Bahia. Highway BR 101, Km 197, Cachoeira, Bahia, Brazil. https://orcid.org/0009-0008-3416-5387
Júlia dos Santos Vianna Néri PhD in Dentistry and Health from the Federal University of Bahia, Bahia, Brazil. Professor of Bahiana School of Medicine and Public Health, Salvador, Bahia, Brazil. https://orcid.org/0000-0003-1805-0949
Daniel Adrian Daniel Adrian Silva Souza Master in the Postgraduate Program in Dentistry and Health from the Federal University of Bahia, Bahia, Brazil. Av. Araújo Pinho, 62, Canela, Salvador, Bahia, Brazil. https://orcid.org/0000-0003-3332-2156
Juliana Borges de Lima Dantas PhD in the Graduate Program in Interactive Processes of Organs and Systems in the Institute of Health Sciences of the Federal University of Bahia. Professor of Bahiana School of Medicine and Public Health, Salvador, Bahia, Brazil. https://orcid.org/0000-0002-9798-9016

DOI:

https://doi.org/10.5327/2525-5711.447

Palavras-chave:

Mucositis, Laser Therapy, Low-Level Light Therapy, Lasers, Semiconductor

Resumo

Introdução: A mucosite oral (MO) é um efeito adverso em pacientes oncológicos e a fotobiomodulação (FBM) melhora a qualidade de vida desses pacientes por meio do manejo da MO. Objetivo: Avaliar os efeitos da FBM extraoral na prevenção e/ou tratamento da MO em pacientes oncológicos. Material e métodos: Esta revisão sistemática foi registrada no PROSPERO, seguindo as diretrizes PRISMA . Foram consultados PubMed, Scopus, Science Direct, LILACS, CAPES , BVS e Google Acadêmico, e utilizadas palavras-chave do DeCS / MeSH . O risco de viés foi analisado utilizando RoB2. Resultados: Foram identificados 593 estudos e selecionados dois artigos. Foram incluídos 115 pacientes, e a FBM extraoral promove ação preventiva e terapêutica na MO, reduz a dor e é bem tolerada. Ao comparar a FBM intraoral e extraoral, ambas obtiveram resultados semelhantes; além disso, a FBM extraoral exigiu um tempo de aplicação menor. Conclusão: O PBM extraoral previne a OM tratada/ed e otimiza o tempo de aplicação em pacientes oncológicos.

Referências

1. Oberoi S, Zamperlini-Netto G, Beyene J, et al. Effect of prophylactic low level laser therapy on oral mucositis: a systematic review and meta-analysis. PLoS One 2014;9(9):107418. doi: 10.1371/journal.pone.0107418.

2. Sonis ST, Elting LS, Keefe D, et al. Perspectives on cancer therapy-Induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer Supp 2004;100(9): 1995-2025.

3. Ramos Pinto MB, Gusmão TPL, Filho JS. Intraoral versus extraoral photobiomodulation therapy in the prevention of oral mucositis in HSCT patients: a randomized, single-blind, controlled clinical trial. Support Care Cancer 2021;29(11):6495-6503. doi: 10.1007/s00520-021-06228-3.

4. Elad S, Cheng KKF, Lalla RV. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 2020;126(19):4423-4431. doi: 10.1002/cncr.33100.

5. Faria KM, Gomes-Silva W, Kauark-Fontes E, et al. Impact of pandemic COVID-19 outbreak on oral mucositis preventive and treatment protocols: new perspectives for extraoral photobiomodulation therapy. Support Care Cancer 2020;28(10):4545-4548. doi: 10.1007/s00520-020-05636-1.

6. Sobral AP, Sobral SS, Campos TM, et al. Photobiomodulation and myofascial temporomandibular disorder: Systematic review and meta-analysis followed by cost-effectiveness analysis. J Clin Exp Dent 2021;13(7):724-32. doi: 10.4317/jced.58084.

7. Aisaiti A, Zhou Y, Wen Y, et al. Efect of photobiomodulation therapy on painful temporomandibular disorders. Sci Reports 2021;11(9049):1-12. doi: 10.1038/s41598-021-87265-0.

8. Fetai A, Debeljak V, Kovačević Pavičić D, et al. Self-massage and low-level laser in treatment of masseter myalgia: short-term effect. Med Acad Most. 2021;9(1):63-70. Disponível em: https://www.psychiatria-danubina.com/UserDocsImages/pdf/dnb_vol33_noSuppl%2010/dnb_vol33_noSuppl%2010_63.pdf

9. Ahmad SA, Hasan S, Saeed S, et al. Low-level laser therapy in temporomandibular joint disorders: a systematic review. J Med Life 2021;14(2):148-164. doi: 10.25122/jml-2020-0169.

10. Kauark-Fontes E, Migliorati CA, Epstein JB, et al. Twenty-year analysis of photobiomodulation clinical studies for oral mucositis: a scoping review. Oral Surg Oral Med Oral Pathol Oral Radiol 2023;135(5):626-641. doi: 10.1016/j.oooo.2022.12.010.

11. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev 2021;10:89. doi: 10.1136/bmj.n71.

12. World Health Organization. WHO handbook for reporting results of cancer treatment. WHO Offset Publication No. 48. Geneva: World Health Organization; 1979.

13. National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0 [Internet]. Bethesda (MD): U.S. Department of Health and Human Services; 2017.

14. Higgins JPT, & Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0; 2011. [internet]. [updated 2011 Mar; cited 2023 Oct 23]. Available from: http://www.cochrane-handbook. org/.

15. Schulz KF, Altman DG, Moher D. CONSORT 2010 state- ment: Updated guidelines for reporting parallel group randomized trials. BMJ 2010;340, 332–332. https://doi.org/10.1136/bmj.c332

16. Higgins JPT, & Altman DG, SJ (Editors). Chapter 8: assessing risk of bias in included studies. Cochrane Handb Syst Rev Interv Version 510 [internet]; 2011. [updated March 2011; cited 2024. https://doi.org/10.1001/jama.2013.109501.

17. Fontes LK, Migliorati CA, Joel BE, et al. Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double blind, clinical trial. Support Care Cancer 2021;30:2225–2236. doi: 10.1007/s00520-021-06625-8.

18. Santos CMC, Pimenta CAM, Nobre MRC. A estratégia PICO para a construção da pergunta de pesquisa e busca de evidências. Rev Latino-Am Enferm. 2007;15(3):1–4. doi: 10.1590/S0104-11692007000300023.

19. Dantas JBL, Martins GB, Lima HR. Evaluation of preventive laser photobiomodulation in patients with head and neck cancer undergoing radiochemotherapy: Laser in patients with head and neck cancer. Spec Care Dentist 2020;40(4):364-373. doi: 10.1111/scd.12486.

20. Martins AFL, Morais MO, De Sousa-Neto SS, et al. Photobiomodulation reduces the impact of radiotherapy on oral health-related quality of life due to mucositis-related symptoms in head and neck cancer patients. Lasers Med Sci 2021;36(4):903-912. doi: 10.1007/s10103-020-03167-z.

21. Adnan A, Yaroslavsky AN, Carroll JD, et al. The Path to an Evidence-Based Treatment Protocol for Extraoral Photobiomodulation Therapy for the Prevention of Oral Mucositis. Front Oral Health. 2021;16(2):689386. doi: 10.3389/froh.2021.689386.

22. Kuhn A, Porto FA, Miraglia P, et al. Low-level infrared laser therapy in chemotherapy-induced oral mucositis: a randomized placebo-controlled trial in children. J Pediatr Hematol Oncol. 2009;31(1):33-7. doi: 10.1097/MPH.0b013e318192cb8e.

23. Ferrari R, Felizardo AC, Siqueira L, et al. Prophylactic photobiomodulation to reduce oral mucositis in head and neck cancer: an observational study. Support Care Cancer. 2025;14;33(11):944. doi: 10.1007/s00520-025-10020-y.

24. Robijns J, Nair RG, Lodewijckx J, et al. Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022. Front Oncol. 2022;12:927685. doi: 10.3389/fonc.2022.927685

25. Soto M, Lalla RV, Gouveia RV, et al. Pilot study on the efficacy of combined intraoral and extraoral low-level laser therapy for prevention of oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation. Photomed Laser Surg. 2015;33(11):540-6. doi: 10.1089/pho.2015.3954.

26. Costa JDR, Dantas JBL, Martins GB, et al. Adherence of head and neck cancer patients to laser photobiomodulation in a public health service: Pilot study. Complement Ther Med. 2021;58:102687–7. doi: 10.1016/j.ctim.2021.102.